Bio-Rad Laboratories Operating Income 2010-2024 | BIO

Bio-Rad Laboratories annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Bio-Rad Laboratories operating income for the quarter ending March 31, 2024 was $0.045B, a 27.79% decline year-over-year.
  • Bio-Rad Laboratories operating income for the twelve months ending March 31, 2024 was $0.321B, a 19.47% decline year-over-year.
  • Bio-Rad Laboratories annual operating income for 2023 was $0.338B, a 30.01% decline from 2022.
  • Bio-Rad Laboratories annual operating income for 2022 was $0.483B, a 3.54% decline from 2021.
  • Bio-Rad Laboratories annual operating income for 2021 was $0.5B, a 18.75% increase from 2020.
Bio-Rad Laboratories Annual Operating Income
(Millions of US $)
2023 $338
2022 $483
2021 $500
2020 $421
2019 $230
2018 $-103
2017 $119
2016 $56
2015 $167
2014 $150
2013 $169
2012 $264
2011 $305
2010 $284
2009 $231
Bio-Rad Laboratories Quarterly Operating Income
(Millions of US $)
2024-03-31 $45
2023-12-31 $95
2023-09-30 $91
2023-06-30 $90
2023-03-31 $62
2022-12-31 $119
2022-09-30 $95
2022-06-30 $123
2022-03-31 $146
2021-12-31 $118
2021-09-30 $157
2021-06-30 $125
2021-03-31 $101
2020-12-31 $186
2020-09-30 $110
2020-06-30 $52
2020-03-31 $74
2019-12-31 $59
2019-09-30 $57
2019-06-30 $56
2019-03-31 $57
2018-12-31 $-227
2018-09-30 $36
2018-06-30 $44
2018-03-31 $44
2017-12-31 $56
2017-09-30 $39
2017-06-30 $-2
2017-03-31 $26
2016-12-31 $-21
2016-09-30 $28
2016-06-30 $23
2016-03-31 $26
2015-12-31 $59
2015-09-30 $33
2015-06-30 $40
2015-03-31 $34
2014-12-31 $51
2014-09-30 $33
2014-06-30 $46
2014-03-31 $20
2013-12-31 $52
2013-09-30 $29
2013-06-30 $53
2013-03-31 $35
2012-12-31 $71
2012-09-30 $66
2012-06-30 $73
2012-03-31 $54
2011-12-31 $96
2011-09-30 $74
2011-06-30 $68
2011-03-31 $67
2010-12-31 $78
2010-09-30 $75
2010-06-30 $68
2010-03-31 $63
2009-12-31 $56
2009-09-30 $67
2009-06-30 $56
2009-03-31 $51
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.790B $2.671B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $180.765B 23.67
Stryker (SYK) United States $129.618B 31.05
Boston Scientific (BSX) United States $112.981B 35.99
Medtronic (MDT) Ireland $100.927B 15.11
EssilorLuxottica (ESLOY) France $99.128B 0.00
Lonza Group Ag (LZAGY) Switzerland $40.585B 0.00
Haleon (HLN) United Kingdom $37.716B 27.53
ResMed (RMD) United States $28.121B 26.40
Terumo (TRUMY) Japan $24.403B 34.46
Koninklijke Philips (PHG) Netherlands $22.841B 18.13
Zimmer Biomet Holdings (ZBH) United States $22.328B 14.26
Baxter (BAX) United States $17.045B 12.12
Insulet (PODD) United States $14.134B 62.67
Smith & Nephew SNATS (SNN) United Kingdom $10.833B 0.00
Demant (WILYY) Denmark $9.370B 0.00
BellRing Brands (BRBR) United States $7.453B 35.06
Lantheus Holdings (LNTH) United States $5.565B 13.87
GN Store Nord (GNNDY) Denmark $4.222B 23.71
Haemonetics (HAE) United States $4.215B 20.79
Perrigo (PRGO) Ireland $3.501B 10.61
Prestige Consumer Healthcare (PBH) United States $3.437B 16.35
Neogen (NEOG) United States $3.386B 32.56
ICU Medical (ICUI) United States $2.893B 25.54
Envista Holdings (NVST) United States $2.858B 11.79
TG Therapeutics (TGTX) United States $2.749B 77.35
Green Thumb Industries (GTBIF) United States $2.552B 49.96
Agios Pharmaceuticals (AGIO) United States $2.448B 0.00
QuidelOrtho (QDEL) United States $2.225B 12.35
LeMaitre Vascular (LMAT) United States $1.847B 54.13
Maravai LifeSciences Holdings (MRVI) United States $1.804B 0.00
Warby Parker (WRBY) United States $1.592B 0.00
InMode (INMD) Israel $1.532B 8.14
AdaptHealth (AHCO) United States $1.332B 9.90
Verano Holdings (VRNOF) United States $1.246B 0.00
AtriCure (ATRC) United States $1.084B 0.00
Owens & Minor (OMI) United States $1.033B 9.00
National Vision Holdings (EYE) United States $1.028B 32.72
BioLife Solutions (BLFS) United States $0.987B 0.00
Cresco Labs (CRLBF) United States $0.771B 0.00
Phibro Animal Health (PAHC) United States $0.679B 14.46
Evolus (EOLS) United States $0.679B 0.00
PetIQ (PETQ) United States $0.656B 21.21
VAREX IMAGING (VREX) United States $0.602B 14.16
Surmodics (SRDX) United States $0.599B 37.54
Quanterix (QTRX) United States $0.506B 0.00
ZimVie (ZIMV) United States $0.498B 42.44
Canopy Growth (CGC) Canada $0.491B 0.00
Valneva SE (VALN) France $0.488B 0.00
Biote (BTMD) United States $0.463B 10.67
Jin Medical (ZJYL) China $0.403B 0.00
TerrAscend (TSNDF) Canada $0.394B 0.00
Cerus (CERS) United States $0.325B 0.00
OraSure Technologies (OSUR) United States $0.315B 10.14
Zynex (ZYXI) United States $0.296B 40.52
MacroGenics (MGNX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 25.19
Aurora Cannabis (ACB) Canada $0.252B 0.00
Sanara MedTech (SMTI) United States $0.243B 0.00
Utah Medical Products (UTMD) United States $0.236B 14.85
Omeros (OMER) United States $0.235B 0.00
Ayr Wellness (AYRWF) United States $0.233B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Holdings (OGI) Canada $0.160B 0.00
FitLife Brands (FTLF) United States $0.153B 21.76
Capricor Therapeutics (CAPR) United States $0.153B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
Quipt Home Medical (QIPT) United States $0.137B 0.00
Veru (VERU) United States $0.123B 0.00
Jushi Holdings (JUSHF) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.104B 0.00
Fonar (FONR) United States $0.101B 10.26
Brainsway (BWAY) Israel $0.101B 0.00
InterCure (INCR) Israel $0.092B 15.46
Cellectar Biosciences (CLRB) United States $0.090B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.073B 4.75
MariMed (MRMD) United States $0.069B 0.00
Safety Shot (SHOT) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.053B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Zevia PBC (ZVIA) United States $0.049B 0.00
Bright Green (BGXX) United States $0.048B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.046B 0.00
United-Guardian (UG) United States $0.041B 14.90
Cytosorbents (CTSO) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Exagen (XGN) United States $0.032B 0.00
Nephros (NEPH) United States $0.022B 0.00
Meihua Medical Technologies (MHUA) China $0.021B 0.00
Agape ATP (ATPC) $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.016B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
FSD PHARMA (HUGE) Canada $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.001B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00